Comment
doi: 10.1002/hep.31100.
Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management
Affiliations
- PMID: 31903611
- DOI: 10.1002/hep.31100
Item in Clipboard
Comment
Letter to the Editor: Hepatocellular Carcinoma Risk in Patients With Nonalcoholic Steatohepatitis Cirrhosis and Diabetes: Insufficient for Individual Management
Hepatology.
2020 Jul.
No abstract available
Comment in
-
REPLY.Hepatology. 2020 Jul;72(1):362-363. doi: 10.1002/hep.31097. Hepatology. 2020. PMID: 31901147 No abstract available.
Comment on
-
Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease.Hepatology. 2020 Mar;71(3):907-916. doi: 10.1002/hep.30858. Epub 2019 Oct 21. Hepatology. 2020. PMID: 31309602 Free PMC article.
Similar articles
-
Letter to the Editor: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in Patients With Nonalcoholic Fatty Liver Disease.Hepatology. 2020 Jun;71(6):2172-2173. doi: 10.1002/hep.31075. Hepatology. 2020. PMID: 31849080 No abstract available.
-
Letter to the Editor: The Association Between Diabetes and Hepatocellular Carcinoma in Patients With Cirrhosis Caused by Nonalcoholic Fatty Liver Disease.Hepatology. 2020 Jul;72(1):363-364. doi: 10.1002/hep.31099. Hepatology. 2020. PMID: 31904864 No abstract available.
-
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014. Clin Liver Dis. 2018. PMID: 29128057 Review.
-
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24. Clin Liver Dis. 2016. PMID: 27063271 Review.
-
[Hepatocellular carcinoma].Internist (Berl). 2017 May;58(5):469-479. doi: 10.1007/s00108-017-0226-z. Internist (Berl). 2017. PMID: 28386626 Review. German.
Cited by
-
Non-receptor Type PTPases and their Role in Controlling Pathways Related to Diabetes and Liver Cancer Signalling.Curr Pharm Biotechnol. 2025;26(5):654-664. doi: 10.2174/0113892010288624240213072415. Curr Pharm Biotechnol. 2025. PMID: 38424416 Review.
-
WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.Onco Targets Ther. 2020 Jul 20;13:7033-7044. doi: 10.2147/OTT.S248570. eCollection 2020. Onco Targets Ther. 2020. PMID: 32801739 Free PMC article.
References
-
- Yang JD, Ahmed F, Mara KC, Addissie BD, Allen AM, Gores GJ, et al. Diabetes is associated with increased risk of hepatocellular carcinoma in cirrhosis patients with nonalcoholic fatty liver disease. Hepatology 2019 Jul 15. https://doi.org/10.1002/hep.30858. [Epub ahead of print]
-
- Tseng CH. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes. Liver Int 2018;38:2018-2027.
-
- Cheuk-Fung Yip T, Wai-Sun Wong V, Lik-Yuen Chan H, Tse YK, Pik-Shan Kong A, Long-Yan Lam K, et al. Effects of diabetes and glycemic control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen. Clin Gastroenterol Hepatol 2018;16:765-773.e2.
-
- Kim GA, Lim YS, Han S, Choi J, Shim JH, Kim KM, et al. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B. Gut 2018;67:945-952.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
